Normalizing Platelet Reactivity After Treatment With Ticagrelor
Phase of Trial: Phase IV
Latest Information Update: 07 Dec 2017
Price : $35 *
At a glance
- Drugs Ticagrelor (Primary) ; Aspirin
- Indications Coronary artery disease
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 13 Sep 2016 Status changed from recruiting to completed.
- 12 Jan 2016 Planned End Date changed from 1 Jan 2016 to 1 Jun 2016, according to ClinicalTrials.gov record.